These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 36296526)

  • 1. Chemical and Synthetic Biology Approaches for Cancer Vaccine Development.
    Hossain F; Kandalai S; Zhou X; Zhang N; Zheng Q
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the molecular design of synthetic vaccines.
    Jones LH
    Nat Chem; 2015 Dec; 7(12):952-60. PubMed ID: 26587710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioconjugation Approaches to Producing Subunit Vaccines Composed of Protein or Peptide Antigens and Covalently Attached Toll-Like Receptor Ligands.
    Xu Z; Moyle PM
    Bioconjug Chem; 2018 Mar; 29(3):572-586. PubMed ID: 28891637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging peptide-based nanovaccines: From design synthesis to defense against cancer and infection.
    Xu F; Yuan Y; Wang Y; Yin Q
    Biomed Pharmacother; 2023 Feb; 158():114117. PubMed ID: 36528914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptides for Vaccine Development.
    Hamley IW
    ACS Appl Bio Mater; 2022 Mar; 5(3):905-944. PubMed ID: 35195008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in synthetic self-adjuvanting vaccine development.
    Ariawan D; van Eersel J; Martin AD; Ke YD; Ittner LM
    Biomater Sci; 2022 Jul; 10(15):4037-4057. PubMed ID: 35708540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical Strategies to Boost Cancer Vaccines.
    Li WH; Li YM
    Chem Rev; 2020 Oct; 120(20):11420-11478. PubMed ID: 32914967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyethyleneimine-based immunoadjuvants for designing cancer vaccines.
    Yang X; Wei Y; Zheng L; You J; Li H; Gao L; Gong C; Yi C
    J Mater Chem B; 2022 Oct; 10(40):8166-8180. PubMed ID: 36217765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with synthetic long peptide formulated with CpG in an oil-in-water emulsion induces robust E7-specific CD8 T cell responses and TC-1 tumor eradication.
    Maynard SK; Marshall JD; MacGill RS; Yu L; Cann JA; Cheng LI; McCarthy MP; Cayatte C; Robbins SH
    BMC Cancer; 2019 Jun; 19(1):540. PubMed ID: 31170937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Cancer Vaccine Research.
    Liu N; Xiao X; Zhang Z; Mao C; Wan M; Shen J
    ACS Biomater Sci Eng; 2023 Nov; 9(11):5999-6023. PubMed ID: 37921277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic peptides as cancer vaccines.
    Sundaram R; Dakappagari NK; Kaumaya PT
    Biopolymers; 2002; 66(3):200-16. PubMed ID: 12385038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Vaccines for Cancer Immunotherapy.
    Wang J; Mamuti M; Wang H
    ACS Biomater Sci Eng; 2020 Nov; 6(11):6036-6052. PubMed ID: 33449675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-specific vaccines for cancer treatment.
    Tagliamonte M; Petrizzo A; Tornesello ML; Buonaguro FM; Buonaguro L
    Hum Vaccin Immunother; 2014; 10(11):3332-46. PubMed ID: 25483639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell-based vaccine: an effective strategy for eradication of cancer cells.
    Sadeghi Najafabadi SA; Bolhassani A; Aghasadeghi MR
    Immunotherapy; 2022 Jun; 14(8):639-654. PubMed ID: 35481358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically modified tumour vaccines--where we are today.
    Nawrocki S; Mackiewicz A
    Cancer Treat Rev; 1999 Feb; 25(1):29-46. PubMed ID: 10212588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outlining novel cellular adjuvant products for therapeutic vaccines against cancer.
    Tefit JN; Serra V
    Expert Rev Vaccines; 2011 Aug; 10(8):1207-20. PubMed ID: 21854313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer vaccines as promising immuno-therapeutics: platforms and current progress.
    Liu J; Fu M; Wang M; Wan D; Wei Y; Wei X
    J Hematol Oncol; 2022 Mar; 15(1):28. PubMed ID: 35303904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing recombinant and synthetic vaccines for the treatment of melanoma.
    Restifo NP; Rosenberg SA
    Curr Opin Oncol; 1999 Jan; 11(1):50-7. PubMed ID: 9914879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fully Synthetic Invariant NKT Cell-Dependent Self-Adjuvanting Antitumor Vaccines Eliciting Potent Immune Response in Mice.
    Chen PG; Hu HG; Sun ZY; Li QQ; Zhang BD; Wu JJ; Li WH; Zhao YF; Chen YX; Li YM
    Mol Pharm; 2020 Feb; 17(2):417-425. PubMed ID: 31841011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.